Verispan News
Most Popular Verispan Story
ALSO NOTED: NMT closes trial; NovaMed raises cash; Sinovac sells shares; Genentech team advances lupus work; and much more...
> NMT Medical says it will close a trial of its migraine technology after experiencing difficulties--and high costs--enrolling patients. Read more...
Latest Headlines
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
